Skip to main content
Have a personal or library account? Click to login
Surgical Cardiac Sympathetic Denervation for Ventricular Arrhythmias: A Systematic ReviewCME Cover

Surgical Cardiac Sympathetic Denervation for Ventricular Arrhythmias: A Systematic ReviewCME

Open Access
|Jan 2021

Figures & Tables

Figure 1

Flow chart for article selection.

Figure 2

Graph comparing various cardiac sympathectomy indications for (A) % mortality and transplantation, (B) % ICD shock-free events, and (C) % ICD shock- and transplant-free survival with error bars indicating 95% confidence intervals. The P value represents comparison of the surgical modality to all bilateral surgical cardiac sympathetic denervation. The asterisk indicates values reaching statistical significance or P < .05. ICD: implantable cardioverter defibrillator

Figure 3

Graph comparing various cardiac sympathectomy surgical modalities for (A) % mortality and transplantation, (B) % ICD shock-free survival, and (C) % ICD shock- and transplant-free survival with error bars indicating 95% confidence intervals. The P value represents comparison of the surgical modality to all bilateral surgical cardiac sympathetic denervation. The asterisk indicates values reaching statistical significance or P < .05. ICD: implantable cardioverter defibrillator

Table 1.

Summary of articles used in the literature review.

FIRST AUTHOR YEAR

JOURNAL

STUDY TYPE

PATIENTS DENERVATED

MEAN AGE (YEARS)

VENTRICULAR ARRHYTHMIA PATIENT POPULATION/INDICATION FOR DENERVATION

FOLLOW-UP (YEARS)

OPERATIVE TECHNIQUE

COMPLICATIONS

EFFECT OF SURGICAL DENERVATION ON MORTALITY, TRANSPLANT, ICD SHOCKS

Yalin 2020

Clin Res Cardiol

Retrospective

10

61.6

Nonischemic cardiomyopathy refractory to meds/catheter ablation

0.84

Left (6) and bilateral (4) thoracoscopic lower stellectomy T2-T4 ganglionectomy Kuntz nerve division if identified

No Horner syndrome, hemopneumothorax (1) 10%

60% ICD shock-free post denervation; 20% mortality (within 1 mo)

Tellez 2019

J Cardiothorac Surg

Case series

20

55.85

Chagas (9); chronic ischemic cardiomyopathy (7); dilated cardiomyopathy (3); long QT syndrome (1) with VA or electrical storm refractory to meds/catheter ablation

0.19

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy

Pneumothorax (1) 5%

90% ICD shock-free post denervation; 5% mortality progression of Chagas disease

Stec 2019

Kardiologia Polska

Case presentation

1

30

Catecholaminergic polymorphic ventricular tachycardia refractory to meds/catheter ablation

0.5

Bilateral thoracoscopic T1-T5

Not reported

100% ICD shock-free post denervation; 0% mmortality

Cai 2019

J Cardiovasc Electrophysiol

Retrospective review

19

54.5

Severe ischemic and nonischemic cardiomyopathy VT storm (15) with VA events refractory to meds/catheter ablation

2.07

Left (14) and bilateral (5) thoracoscopic inferior stellectomy T2-T4 ganglionectomy

Not reported

47% ICD shock-free post denervation; 21% mortality mean follow-up 2.8 yrs; 26.3% transplanted

Assis 2019

Heart Rhythm

Case series

8

32

Arrhythmogenic right ventricular cardiomyopathy with VA events refractory to meds/catheter ablation

1.9

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy

Venous plexus injury (1) 12.5%, neuropathic pain (1) 12.5%, pneumothorax (1) 12.5%

63% ICD shock-free post denervation; 0% mortality

Velasquez 2019

Arch Cardiol Mex

Case series

6

56.83

Ischemic or hypertensive cardiomyopathy (4); long QT syndrome (2) with VA events refractory to meds/catheter ablation

2

Left thoracoscopic inferior stellectomy T2-T4 ganglionectomy

None found after retrospective investigation

83% ICD shock-free post denervation; 0% mortality; 50% VA recurrence free

Okada 2019

Heart Rhythm

Case series

5

53

Cardiac sarcoidosis electrical storm (3) VA events refractory to meds/catheter ablation

1.55

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy Kuntz nerve division if identified

Azygous vein injury, hemothorax (1) 20%No Horner syndrome or compensatory hyperhidrosis

100% ICD shock-free post denervation; 0% mortality; 60% no recurrence of sustained VA; 20% transplant, no mortalities

Kopecky 2018

Pacing Clin Electrophysiol

Case presentation

1

69

Viral cardiomyopathy low left ventricular ejection fraction 20-30% with VA events refractory to meds/ablation

0.5

Bilateral T1-T4 sympathectomy

None identified

100% ICD shock-free post denervation; 0% mortality

Krishnan 2018

Ann Thorac Surg

Case presentation

1

50

Nonischemic cardiomyopathy in VA electrical storm

1

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy Kuntz nerve division when seen

No Horner syndrome, no reactive hyperhidrosis

100% ICD shock-free post denervation0% Mortality; no heart palpitation symptoms, delisted for heart transplant

Richardson 2018

Heart Rhythm

Case series

7

50.9

Nonischemic/ischemic cardiomyopathy (2, 2); hypertrophic cardiomyopathy (1); normal heart idiopathic (2); electrical storm (1) with VA events refractory to meds/catheter ablation

1.17

Left (1) or bilateral (6) division of sympathetic chain over the 2nd and 3rd ribs

No Horner syndrome, compensatory hyperhidrosis (1) 14.3%, chest tube insertion (1) 14.3%

100% ICD shock-free post denervation; 14.3% transplanted; no sustained VA in follow-up

Wehman 2018

Ann Thorac Surg

Case presentation

1

49

Coronary artery bypass patient with post operative electrical storm

Not reported

Left thoracoscopic stellectomy

No Horner syndrome

100% ICD shock-free post denervation; 0% mortality; no sustained VA until discharge to rehab

Cardona-Guarache 2017

J Cardiovasc Electrophysiol

Case series

3

47.3

Coronary artery spasm patients with VA refractory to meds/catheter ablation

0.52

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy

No procedural complications

100% ICD shock free post denervation; 0% mortality

Vaseghi 2017

JACC

Retrospective multicenter registry

121

55

Variable disease processes with refractory ventricular arrhythmia or electrical storm refractory to meds/catheter ablation

1.5

Bilateral (98) and left (23) thoracoscopic inferior stellectomy T2-T4 ganglionectomy; Kuntz nerve division if identified

Hemothorax (3) 2.5%Pneumothorax (6) 5%Horner (5) 4.1%, resolution in 4/5Hypotension requiring pressors (16) 13.2%Cellulitis (2) 1.7%Urinary tract infection (1) 0.8%Nausea and vomiting (1) 0.8% Multifocal pneumonia (1) 0.8%)

84.3% ICD shock-free post denervation; 25.6% mortality; 8.2% transplanted; 58% free of VA/ICD shock at 1 yr, 49% at mean 1.5 yrs; 76.2% free of death/transplant at 1 yr; 50% free of ICD shock, transplant/death at 1 yr; bilateral = left denervation for freedom of ICD shock; bilateral < left denervation for ICD shock, transplant, death at 1 yr

Jang 2017

Pacing Clin Electrophysiol

Case series

15

24.6

Long QT syndrome (14); catecholaminergic polymorphic ventricular tachycardia (1)

2.5

Left thoracoscopic inferior stellectomy T2-T4 ganglionectomy

No Horner, no bleeding, no pneumothorax

86.7% ICD shock-free post denervation; 0% mortality; 0.97-0.19 cardiac events/yr after denervation (P = .045)

Prabhu 2016

J Interv Card Electrophysiol

Retrospective

7

52

Ischemic cardiomyopathy (78%); nonischemic cardiomyopathy (22%) in electrical storm refractory to meds/catheter ablation

2.75

Left thoracoscopic (4) and surgical (3) lower-half stellectomy T2-T4 ganglionectomy

Ptosis (4) 57.1%, 3 recovered Partial anhydrosis left upper extremity (2) 28.6%

28.6% ICD shock-free post denervation28.6% Mortality (within 48 hrs)71.4% Recurrence of VA cardiac events

Saenz 2016

Heart Rhythm

Retrospective review

7

51.86

Chagasic cardiomyopathy with electrical storm (6); refractory VA (1) refractory to meds/catheter ablation

1.29

Bilateral thoracoscopic inferior stellectomy T2-T4 ganglionectomy Kuntz nerve division

Thoracic hyperalgesia (1) 14.2%

57.1% ICD shock-free post denervation14.3% Mortality

Methangkool 2014

J Cardiothorac Vasc Anesth

Retrospective review

26

58

Ischemic/nonischemic cardiomyopathy (23%,54%); electrical storm (23%) refractory to meds/catheter ablation

0.93 (4 lost to follow-up

Bilateral (11) and left (15) thoracoscopic stellate, sympathetic ganglionectomy

No Horner syndrome, pneumothorax (2) 7.7%

30.7% ICD shock-free post denervation12% Mortality, 8% transplanted No mortality within 24 hrs8% 7-day mortality, 12% 30-day mortality, 88.5% 1-yr mortality

Ajijola 2012

J Am Coll Cardiol

Retrospective review

6

60.17

Nonischemic cardiomyopathy (4); sarcoid (1); arrhythmogenic right ventricular cardiomyopathy (1); electrical storm (6) refractory to meds/catheter ablation and poor transplant candidates (6)

0.33

Bilateral or left followed by right thoracoscopic inferior stellectomy, T2-T4 ganglionectomy

Mortality linked to worsening heart failure after surgical denervation (1) 16.7%

66% ICD shock-free post denervation; 33% mortality (within 1 mo); 16.7% no response, mortality within days of procedure; 16.7% partial response, decreased VA cardiac events

Gopinathannair 2010

European Society of Cardiology

Case presentation

1

22

Catecholaminergic polymorphic ventricular tachycardia refractory to meds with poor exercise tolerance

1.33

Left thoracoscopic sympathectomy at levels T1-T5

No complications

100% ICD shock-free post denervation; 0% mortality; mild/marked improvement exercise tolerance at 1 mo/3 mo; asymptomatic at 16 mo

Bourke 2010

Circulation

Retrospective review

9

54.2

Ischemic (2), nonischemic (2), hypertrophic (2), sarcoid (2), arythmogenic right ventricular dysplasia (1), electrical storm (8), incessant storm (4), and recurrent VA (1) refractory to meds/catheter ablation

0.52

Left thoracoscopic: entire stellectomy to T2 (3),inferior stellectomy to T2 (2), and inferior stellectomy to T4 (4) ganglionectomy

Horner (1) 11.1%, resolved in 6 mo, anhydrosis (1) 11.1%, pneumothorax (1) 11.1%

33% ICD shock-free post denervation; 22% mortality; 22% decreased VA cardiac events; 44% no difference after treatment; 77% survival to discharge

Gutierrez 2007

Int J Cardiol

Case presentation

1

29

Chagasic myocarditis with recurrent VA refractory to meds/catheter ablation

0.75

Bilateral thoracoscopic T2, T3, T4 ganglia ablation

Not reported

100% ICD shock-free post denervation; 100% mortality (at 9 mo unknown cause); nonsustained polymorphic VT episodes at 8 mo

Table 2.

Outcomes for the surgical cardiac sympathetic denervation disease indications comparing various ventricular arrhythmia indications to the overall pooled disease indications. The P value represents comparison of the surgical indication to all indications. The asterisk indicates values reaching statistical significance or P < .05.

INDICATION

INCLUDED STUDIES (#)

PATIENTS DENERVATED

MEAN AGE (YEARS)

AGE RANGE (YEARS)

AVERAGE FOLLOW-UP (YEARS)

FOLLOW-UP RANGE

% MORTALITY & TRANSPLANT(95% CI)

MORTALITY/TRANSPLANT P VALUE

% ICD SHOCK FREE AFTER DENERVATION (95% CI)

ICD SHOCK FREE P VALUE

% ICD SHOCK-/TRANSPLANT-FREE SURVIVAL

ICD SHOCK-/TRANSPLANT-FREE SURVIVAL P VALUE

REFERENCES

All indications (baseline)

21

275

51.6

20 to 80

1.38

Mean range0.19 to 2.75

29.5% (24.4-35.1)

n/a

62.2% (56.3-67.7)

n/a

52.4% (46.5-58.2)

n/a

Ischemic, nonischemic cardiomyopathy

9

168

55.28

20 to 80

0.91

0.5 to 2.07

28.6% (22.3-35.8)

0.914

61.9% (54.4-68.9)

> .999

52.4% (44.7-59.8)

> .999

10,12,18,22,23,25,27,28,29

Chagasic cardiomyopathy

3

17

55.88

29 to 73

0.75

0.5 to 1.29

17.6% (6.2-41.4)

0.415

64.7% (41.3-82.7)

> .999

52.9% (31.0-73.8)

> .999

16,24,26

Electrical storm for any indication

8

51

55.35

25 to 75

0.85

0.019 to 3

54.9% (41.4-67.7)*

0.001*

49% (35.9-62.3)

0.088

33.3% (22.0-47.0) *

0.015 *

10,12,19-21,22,24,28

Sarcoidosis cardiomyopathy

3

8

49.63

25 to 71

1.13

0.17 to 2.41

25% (4.4-59.1); 12.5% mortality only

> .999

75% (40-9-95.6)

0.714

62.5% (30.7-86.3)

0.726

10,12,21

Arrhythmogenic right ventricular cardiomyopathy

3

10

35.7

18 to 75

1.57

0.07 to 3.56

20% (3.0-44.8); 10% mortality only

0.914

80% (49.0-96.4)

0.411

60% (31.3-83.2)

0.753

10-12

Table 3.

Summary of the outcomes comparing various surgical modalities for cardiac sympathetic denervation. The P value represents comparison of the surgical modality to all bilateral surgical cardiac sympathetic denervation. The asterisk indicates values reaching statistical significance or P < .05.

SURGICAL MODALITY

INCLUDED STUDIES (#)

PATIENTS DENERVATED

MEAN AGE (YEARS)

AGE RANGE (YEARS)

MEAN FOLLOW-UP (YEARS)

MEAN FOLLOW-UP RANGE (YEARS)

% MORTALITY/TRANSPLANT (95% CI)

MORTALITY/TRANSPLANT P VALUE

% ICD SHOCK-FREE AFTER DENERVATION (95% CI)

ICD SHOCK-FREE P VALUE

% ICD SHOCK-/TRANSPLANT-FREE SURVIVAL AFTER DENERVATION (95% CI)

ICD SHOCK-/TRANSPLANT-FREE SURVIVAL P VALUE

REFERENCES

All bilateral thoracoscopic denervation procedures (baseline)

12

161

53.38

20 to 80

1.24

0.19 to 1.9

19.3% (13.9-26.0)

n/a

59.0% (51.3-66.3)

n/a

10,11,14, 16,18,19,21, 23-26,29

Bilateral thoracoscopic denervation with lower half stellectomy T2-T4 ganglionectomy with Kuntz nerve division if identified

7

143

53.40

20 to 73

1.3

0.19 to 1.9

18.9% (13.3-26.0)

> .999

57.3% (49.1-65.2)

0.816

8,11,19,21,24,26,29

All left thoracoscopic denervation procedures

9

69

48.37

22 to 80

1.7

0.52 to 2.75

31.9% (22.1-43.6)*

.042*

53.6% (42.0-64.9)

0.47

8,12,15,17,22,23,27-29

Table 4.

Reported complications after surgical cardiac sympathetic denervation.

Surgical complication encountered(18 studies included)

% Complications

Pneumothorax

5.5% (14/254)

Horner's syndrome

4.3% (11/254)

Hemothorax

1.97 (5/254)

Azygous vein/venous plexus injury

0.79% (2/254)

Neuropathic pain

0.79% (2/254)

Cellulitis/wound infection

0.79% (2/254)

Upper extremity anhidrosis

0.79% (2/254)

Compensatory hyperhidrosis

0.39% (1/254)

Worsening heart failure/mortality

0.39% (1/254)

Pnemonia

0.39% (1/254)

Nausea vomiting

0.39% (1/254)

Urinary tract infection

0.39% (1/254)

DOI: https://doi.org/10.14797/QIQG9041 | Journal eISSN: 1947-6108
Language: English
Page range: 24 - 35
Published on: Jan 1, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2021 Ray K Chihara, Edward Y Chan, Leonora M Meisenbach, Min P Kim, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.